ask="0.7200"
ask_size="2500"
average_daily_volume="3873950"
bid="0.6500"
bid_size="500"
book_value="0.1680"
change="-0.0171"
change_from_200_day_moving_average="0.3281"
change_from_50_day_moving_average="0.2775"
change_from_52_week_high="-0.0671"
change_From_52_week_low="0.4109"
change_in_percent="-2.4084%"
close="0.6929"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.7200"
high_52_weeks="0.7600"
last_trade_date="3/7/2017"
last_trade_price="0.6929"
last_trade_size="2823"
last_trade_time="4:00pm"
low="0.6925"
low_52_weeks="0.2820"
market_capitalization="178.17M"
moving_average_200_day="0.3648"
moving_average_50_day="0.4154"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.0000"
open="0.7100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+89.9506%"
percent_change_from_50_day_moving_average="+66.7914%"
percent_change_from_52_week_high="-8.8289%"
percent_change_from_52_week_low="+145.7092%"
previous_close="0.7100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.2262"
price_per_sales="3.3517"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.2600"
stock_exchange="NCM"
symbol="PPHM"
volume="3011609"
weeks_range_52="0.2820 - 0.7600"
